Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Within the complex and evolving therapeutic and competitive landscapes, there is a need for better methods of rapidly and more objectively assessing assets and portfolio positioning. The traditional approach uses secondary research and is a lengthy, manual process that is not objective and is potentially more prone to errors due to outdated or missed information.
In this webinar, data science experts will discuss how using artificial intelligence can assist teams with these and other challenges by:
Using AI/ML-based solutions, customers can:
Lucas Glass
Vice President, Analytics Center of Excellence, IQVIA
Greg Lever
AI Solutions Delivery Director, IQVIA
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
IQVIA's Drug Discovery & Development Services use AI and machine learning to transform R&D and expedite the drug discovery and development process.